Obstetrics & Gynecology Doctors in Alexander City, AL Accepting Medicare

5 Obstetrics & Gynecology doctors found. Showing 1 - 5

Rory Adam Clawser, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3368 Highway 280 Ste 111, Alexander City, AL 35010 Phone: 256-234-3477

Dr. James Victor Hamilton Ii, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 44 Aliant Pkwy, Alexander City, AL 35010 Phone: 256-234-4131    Fax: 256-234-9979

William Harrison Moore Jr., M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Suite 111, Alexander City, AL 35010 Phone: 256-234-3477    Fax: 256-234-9866

Dr. Davis Lee Sullivan, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 59 Alison Dr Ste 8, Alexander City, AL 35010 Phone: 256-234-3477

Katharine R Cooper, M.D. Obstetrics & Gynecology - Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3368 Highway 280, Suite 205, Alexander City, AL 35010 Phone: 256-234-2464    Fax: 256-234-2440

News Archive

Study shows image fusion guided biopsy improves accuracy of prostate cancer diagnosis

A recent study by investigators from LIJ Medical Center demonstrated that using magnetic resonance imaging (MRI) in men with an elevated prostate specific antigen (PSA) resulted in a prostate cancer detection rate that was twice as high as data reported in the March 1999 Prostate journal that analyzed men undergoing the standard 12-core biopsy with an elevated PSA.

Nektar Therapeutics to present data of NKTR-102 Phase 2 clinical trial in ovarian cancer at 46th ASCO

Nektar Therapeutics today announced that results from the Phase 2 clinical trial of NKTR-102 in women with platinum-resistant/refractory ovarian cancer will be presented at the Oral Abstract Session of the Gynecologic Cancer Track during the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).

Patients in dialysis centers demonstrated better clinical results after acquired by DaVita, study shows

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), today released a study finding patient outcomes in the company's newly acquired centers showed dramatic improvements over the two years following their switch to DaVita® ownership.

FDA approves Prior Approval Supplement for EMBEDA Extended Release Capsules CII

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved a Prior Approval Supplement for EMBEDA (morphine sulfate and naltrexone hydrochloride) Extended Release Capsules CII.

Read more Medical News

› Verified 5 days ago